Michael W Stewart
Overview
Explore the profile of Michael W Stewart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
1477
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
12.
Evaluating Access to Laser Eye Surgery by Driving Times Using Medicare Data and Geographical Mapping
Shaffer J, Rajesh A, Stewart M, Lee A, Miller D, Lee C, et al.
JAMA Ophthalmol
. 2023 Jul;
141(8):776-783.
PMID: 37471084
Importance: Recently, several states have granted optometrists privileges to perform select laser procedures (laser peripheral iridotomy, selective laser trabeculoplasty, and YAG laser capsulotomy) with the aim of increasing access. However,...
13.
Anisetti B, Stewart M, Eggenberger E, Shourav M, Youssef H, Elkhair A, et al.
J Stroke Cerebrovasc Dis
. 2023 Jul;
32(8):107244.
PMID: 37422928
Background: Age-related macular degeneration (AMD) is a common retinal degenerative disorder among older individuals. Amyloid deposits, a hallmark of cerebral amyloid angiopathy (CAA), may be involved in the pathogenesis of...
14.
Sheng Y, Jain M, Sahoo N, Reddy N, Tyagi M, Narula R, et al.
Retin Cases Brief Rep
. 2023 Jun;
PMID: 37343512
Purpose: To describe the characteristics and outcomes of eyes with idiopathic full-thickness macular holes (FTMH) that underwent initial medical management. Methods: This retrospective study included eyes with FTMH that were...
15.
Wagner I, Stewart M, Dorairaj S
Mayo Clin Proc Innov Qual Outcomes
. 2022 Nov;
6(6):618-635.
PMID: 36405987
Glaucoma is the leading cause of blindness throughout the world (after cataracts); therefore, general physicians should be familiar with the diagnosis and management of affected patients. Glaucomas are usually categorized...
16.
Kedarisetti K, Narayanan R, Stewart M, Reddy Gurram N, Khanani A
Clin Ophthalmol
. 2022 Oct;
16:3297-3309.
PMID: 36237488
Macular telangiectasia Type 2 (MacTel) is a gradually progressive disease that affects the quality of life by impairing both distant and near vision. It had previously been considered a vascular...
17.
Stewart M, Garg S, Newman E, Jeffords E, Konopinska J, Jackson S, et al.
Retina
. 2022 May;
42(6):1038-1046.
PMID: 35537111
Purpose: To evaluate the safety and therapeutic effects of orally administered AKST4290 (formerly BI 144807 and ALK4290) in treatment-naive patients with neovascular age-related macular degeneration. Methods: In this prospective, multicenter,...
18.
Stewart M
Ophthalmol Ther
. 2022 Apr;
11(3):931-938.
PMID: 35461399
Ophthalmologists frequently face patients who refuse asepsis protocols involving povidone-iodine (PI) due to claims of an allergy to iodine. Such patients usually base this claim on previous reactions to shellfish...
19.
Chaudhary V, Matonti F, Zarranz-Ventura J, Stewart M
Retina
. 2021 Aug;
42(4):589-606.
PMID: 34393212
Purpose: Understanding the impact of fluid in different retinal compartments is critical to developing treatment paradigms that optimize visual acuity and reduce treatment burden in neovascular age-related macular degeneration. This...
20.
Eissing T, Stewart M, Qian C, Rittenhouse K
Transl Vis Sci Technol
. 2021 May;
10(4):9.
PMID: 34003985
Purpose: To investigate whether vascular endothelial growth factor (VEGF)-suppression durations contribute to our understanding of clinical trial outcomes by simulating vitreous molar concentrations (Cvm) of intravitreal aflibercept (IVT-AFL) and brolucizumab...